| Fibroblast Growth Factor Regeneration of Tympanic Membrane Perforations (NCT04960384) | NYU Langone Health | 2022-05-27 |
| Efficacy of Polyethylene Glycol vs Lactulose With Isabgol in Acute Fissure-in-Ano: PEGASIS Trial (NCT05341180) | All India Institute of Medical Sciences, Bhubaneswar | 2022-05-27 |
| CFI-402257, a Potent and Selective TTK Inhibitor, in Solid Tumors and With Fulvestrant in Breast Cancer (NCT05251714) | Treadwell Therapeutics, Inc | 2022-05-27 |
| A Feasibility Study of Octreotide Infusion During Liver Transplant. (NCT04941911) | University College, London | 2022-05-27 |
| Effect of Ensifentrine on Sputum Markers of Inflammation in COPD (NCT05270525) | Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA | 2022-05-27 |
| A Study of Mosunetuzumab Alone or With Zanubrutinib in People With Follicular Lymphoma (NCT05389293) | Memorial Sloan Kettering Cancer Center | 2022-05-27 |
| A Study of Lorlatinib in Subjects With ROS1-Positive Non-Small Cell Lung Cancer (NCT05297890) | CStone Pharmaceuticals | 2022-05-27 |
| A Study of Oral ARD-101 in Patients With Prader-Willi Syndrome (NCT05153434) | Aardvark Therapeutics, Inc. | 2022-05-27 |
| 3-D Super Resolution Ultrasound Microvascular Imaging (NCT04136912) | UNC Lineberger Comprehensive Cancer Center | 2022-05-26 |
| Autologous Muscle Derived Cells for Treatment of Tongue Dysphagia (NCT05421689) | University of California, Davis | 2022-05-26 |
| A Study of RC48-ADC Combined With JS001 For Perioperative Treatment of Muscle-Invasive Bladder Cancer (NCT05297552) | RemeGen Co., Ltd. | 2022-05-26 |
| Effectiveness of CRD-740 in Heart Failure (NCT05409183) | Cardurion Pharmaceuticals, Inc. | 2022-05-26 |
| Phase II Trial of VDJ001 in Patients With Moderate-to-severe Active Rheumatoid Arthritis (NCT05957107) | Beijing VDJBio Co., LTD. | 2022-05-26 |
| Erenumab-aooe for Temporomandibular Disorders Management: TMD Cgrp Antibody RElief (TMD CARE) (NCT05162027) | University of Maryland, Baltimore | 2022-05-26 |
| Pembrolizumab With Standard Cytotoxic Chemotherapy in Treatment Naive NSCLC Patients With Asymptomatic Brain Metastases (NCT04967417) | Samsung Medical Center | 2022-05-26 |
| A Study of ZG19018 in Patients With KRAS G12C Mutant Advanced Solid Tumors. (NCT06237400) | Suzhou Zelgen Biopharmaceuticals Co.,Ltd | 2022-05-26 |
| Study of LM-108 as a Single Agent or in Combination With Pembrolizumab in Subjects With Advanced Solid Tumours (NCT05255484) | LaNova Medicines Limited | 2022-05-26 |
| To Evaluate SSD8432/Ritonavir in Adults With COVID-19 (NCT05373433) | Jiangsu Simcere Pharmaceutical Co., Ltd. | 2022-05-26 |
| JINZHEN for Treatment of Mild to Moderate COVID-19 (NCT05092503) | Lianyungang Kanion Group, Ltd. | 2022-05-26 |
| 28-Day Study of SAGE-718 on Functioning Capacity in Participants With Huntington's Disease (NCT05358821) | Supernus Pharmaceuticals, Inc. | 2022-05-26 |
| REduced Frequency ImmuNE Checkpoint Inhibition in Cancers (NCT04913025) | University College, London | 2022-05-26 |
| Trial of Ulixertinib in Combination With Hydroxychloroquine in Patients With Advanced Gastrointestinal (GI) Malignancies (NCT05221320) | BioMed Valley Discoveries, Inc | 2022-05-26 |
| GLP-1 Analogue in Preventing Progression of Small Vessel Disease (GAPP-SVD) (NCT05356104) | Chinese University of Hong Kong | 2022-05-25 |
| Proof-of-concept Trial of Apraglutide in Acute Graft Versus Host Disease (aGVHD) (NCT05415410) | VectivBio AG | 2022-05-25 |
| Effects of Quetiapine on Sleep and Next Day Alertness in People With Obstructive Sleep Apnea (NCT05303935) | Flinders University | 2022-05-25 |
| Comparison of Erector Spinae Block and Pecto-Intercostal Facial Block For Enhanced Recovery in Adult Cardiac Surgery (NCT05475561) | Alexandria University | 2022-05-25 |
| A Study Evaluating the Efficacy of 5-FU + NALIRI and 5-FU + NALIRINOX for PDAC (NALPAC) (NCT05472259) | Belgian Group of Digestive Oncology | 2022-05-25 |
| BotulInum Toxin Type A for Peripheral Neuropathic Pain in subjEcts With Carpal Tunnel Syndrome (NCT05411900) | Francesco Bono | 2022-05-25 |
| Venetoclax + Cytarabine Versus Idarubicin + Cytarabine : Efficacity Assessment as Post-remission Therapy to Elderly Patients With Acute Myeloid Leukemia in First Remission (NCT04968015) | French Innovative Leukemia Organisation | 2022-05-25 |
| Chidamide Bridging for CAR-T Therapy (NCT05370547) | Chinese PLA General Hospital | 2022-05-25 |
| CNS Dose Escalation/Expansion of Tepotinib in MET-driven NSCLC (NCT04739358) | Criterium, Inc. | 2022-05-25 |
| Sleep Trial to Prevent Alzheimer's Disease (NCT04629547) | University of Minnesota | 2022-05-25 |
| Efficacy and Safety of Tian Ma Bian Chun Zhi Gan Tablets in Mild to Moderate Vascular Dementia (NCT05371639) | Dongzhimen Hospital, Beijing | 2022-05-25 |
| OH2 Oncolytic Viral Therapy in Advanced Bladder Cancer (NCT05248789) | Binhui Biopharmaceutical Co., Ltd. | 2022-05-25 |
| A Clinical Trial on Sequential Immunization of Recombinant COVID-19 Vaccine (CHO Cell, NVSI-06-09) and Inactivated COVID-19 Vaccine (Vero Cell) (NCT05293548) | National Vaccine and Serum Institute, China | 2022-05-25 |
| Post-Acute COVID-19, Inflammation, and Depression (NCT05346120) | Sean Savitz | 2022-05-25 |
| A Study of LVGN6051 Combined With Anlotinib in Patient With Soft Tissue Sarcoma (NCT05301764) | Lyvgen Biopharma Holdings Limited | 2022-05-25 |
| A Study of YL201 in Patients With Advanced Solid Tumors (NCT05434234) | MediLink Therapeutics (Suzhou) Co., Ltd. | 2022-05-25 |
| Targeting the Endothelial Glycocalyx to Enhance Vascular Function and Exercise-Induced Vascular Adaptations in Type 2 Diabetes (NCT05205005) | VA Office of Research and Development | 2022-05-25 |
| Intraoperative Tumor Margin Identification With ICG Dye Imaging (NCT04752137) | Massachusetts General Hospital | 2022-05-25 |
| Investigation of Sulindac (HLX-0201) and Gaboxadol (HLX-0206) in Male Fragile X Syndrome Patients Aged 13-40 (NCT04823052) | Healx Limited | 2022-05-25 |
| Investigator-Initiated Study of Imipramine Hydrochloride and Lomustine in Recurrent Glioblastoma (NCT04863950) | The University of Texas Health Science Center at San Antonio | 2022-05-25 |
| Phase 2 Study of VGT-309 in Lung Cancer (NCT05400226) | Vergent Bioscience, Inc. | 2022-05-24 |
| A Clinical Trial to Evaluate the Efficacy, Tolerability, and Safety of a Fixed Dose Combination of Spironolactone, Pioglitazone & Metformin (SPIOMET) in Polycystic Ovary Syndrome (PCOS) (NCT05394142) | Fundació Sant Joan de Déu | 2022-05-24 |
| Exploratory Efficacy of N-Acetylcysteine in Patients With History of COVID-19 (NCT05736887) | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 2022-05-24 |
| Study to Assess Safety, Tolerability and Efficacy of MB-106 in Patients With Relapsed or Refractory B-Cell NHL or CLL (NCT05360238) | Mustang Bio | 2022-05-24 |
| Interleukin-1 Blockade in Acute Myocardial Infarction to Prevent Heart Failure (NCT05177822) | Virginia Commonwealth University | 2022-05-24 |
| Capsaicin Cream as an Adjunctive Therapy for Nausea and Vomiting of Pregnancy (NCT05098067) | Women and Infants Hospital of Rhode Island | 2022-05-24 |
| Azacitidine in Combination With Low Dose Intensity Venetoclax in Patients With AML Incl. Explorative AML Profiling (NCT05431257) | Rigshospitalet, Denmark | 2022-05-24 |
| A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations (NCT05199584) | Endeavor Biomedicines, Inc. | 2022-05-24 |
| A Phase Ib/II Study of SHR-A1811 Injection in Breast Cancer (NCT05353361) | Jiangsu HengRui Medicine Co., Ltd. | 2022-05-23 |
| CVM-1118 in Combination With Nivolumab for Unresectable Advanced Hepatocellular Carcinoma (NCT05257590) | TaiRx, Inc. | 2022-05-23 |
| Study of Efficacy and Safety of AVTR101 in Sarcopenic Elderly (NCT06788236) | Aventi Biotechnology Inc. | 2022-05-23 |
| The Communicate Study Partnership (NCT05629416) | Menzies School of Health Research | 2022-05-23 |
| Clinical Study of Chidamide Combined With Chemotherapy in Neoadjuvant Treatment of HR+/ HER2-BC (NCT05400993) | Shengjing Hospital | 2022-05-23 |
| Efficacy and Safety Study of F520 Combined With Lenvatinib in the Treatment of Patients With Advanced Solid Tumors (NCT05740215) | Shandong New Time Pharmaceutical Co., LTD | 2022-05-23 |
| Donor Lymphocyte Infusion After Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic Malignancies (NCT05327023) | National Cancer Institute (NCI) | 2022-05-23 |
| A Study of Unesbulin in Participants With Advanced Leiomyosarcoma (LMS) (NCT05269355) | PTC Therapeutics | 2022-05-23 |
| Immunotherapy With Durva and Treme With or Without Capecitabine in Adjuvant Treatment for Biliary Tract Cancer (NCT05239169) | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | 2022-05-23 |
| A Study of ARX788 Combined With Pyrotinib Maleate Versus TCBHP (Trastuzumab Plus Pertuzumab With Docetaxel and Carboplatin) as Neoadjuvant Treatment in HER2-positive Breast Cancer Patients (NCT05426486) | Caigang Liu | 2022-05-23 |
| A Phase II Clinical Trial of TQC3721 Suspension for Inhalation (NCT05292196) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2022-05-20 |
| Randomized Phase II, Open-label Efficacy and Safety Study of Second-line Durvalumab Plus Tremelimumab Versus Platinum-based Chemotherapy Alone in Patients With NSCLC and First-line Checkpoint-inhibitor Therapy (Re-Check) (NCT05383001) | AIO-Studien-gGmbH | 2022-05-20 |
| Efficacy and Safety of Edoxaban in Patients With Atrial Fibrillation and Mitral Stenosis (NCT05540587) | Sung-Hwan Kim | 2022-05-20 |
| Study of Epetraborole in Patients With Treatment-refractory MAC Lung Disease (NCT05327803) | AN2 Therapeutics, Inc | 2022-05-20 |
| A Study of Whether Ide-cel (bb2121) Can Be Made From People With Multiple Myeloma Who Have Had a Hematopoietic Cell Transplant (NCT05393804) | Memorial Sloan Kettering Cancer Center | 2022-05-20 |
| Oxytocin on Cold Water Task Performance and Recovery (NCT04738838) | Florida Institute for Human and Machine Cognition | 2022-05-20 |
| Safety and Feasibility of Dasatinib and Quercetin in Adults at Risk for Alzheimer's Disease (NCT05422885) | Lewis Lipsitz | 2022-05-20 |
| A Study of TG103 Injection in Overweight or Obesity (NCT05299697) | CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. | 2022-05-20 |
| NEO-adjuvant Chemo-immunotherapy in Pancreatic Cancer (NCT06094140) | Australasian Gastro-Intestinal Trials Group | 2022-05-20 |
| Sympathetic Mechanisms in Obesity-Crossover Design (NCT05312892) | Vanderbilt University Medical Center | 2022-05-20 |
| SKB264 Combinatiton Therapy in Patients With Advanced or Metastatic Non-small Cell Lung Cancer. (NCT05351788) | Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | 2022-05-20 |
| Evaluation of SSD8432 and Ritonavir in Adult Subjects With COVID-19 Clinical Study (NCT05373446) | Jiangsu Simcere Pharmaceutical Co., Ltd. | 2022-05-20 |
| Clinical Safety and Efficacy Evaluation of NanoLithium® NP03 in Patients With Mild-to-severe Alzheimer's Disease (NCT05423522) | Medesis Pharma SA | 2022-05-20 |
| Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Previously Treated Glioblastoma or Other Primary Central Nervous System Tumors Harboring Activating FGFR1-3 Alterations (NCT05267106) | Incyte Corporation | 2022-05-20 |
| MK-7075 (Miransertib) in Proteus Syndrome (NCT04316546) | National Human Genome Research Institute (NHGRI) | 2022-05-20 |
| Treatment of Dalpiciclib Combined With Pyrotinib for Trastuzumab-sensitive HER2+ Advanced Breast Cancer(DAP-Her-02) (NCT05328440) | Henan Cancer Hospital | 2022-05-20 |
| A Single Ascending Dose Cohort Study of AG-73305 in DME Patients (NCT05301751) | Allgenesis Biotherapeutics Inc. | 2022-05-19 |
| Study Comparing Standard of Care Chemotherapy With/ Without Sequential Cytoreductive Surgery for Patients With Metastatic Foregut Cancer and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid Levels (NCT04931420) | University of Chicago | 2022-05-19 |
| Treatment With Human Umbilical Cord Mesenchymal Stem Cells for Refractory Diabetic Peripheral Neuropathy (NCT05507697) | Wuhan Central Hospital | 2022-05-19 |
| Open-label Study of ELA026 in Participants With Secondary Hemophagocytic Lymphohistiocytosis (sHLH) (NCT05416307) | Electra Therapeutics Inc. | 2022-05-19 |
| Neoadjuvant Lazertinib Therapy in EGFR-Mutation Positive Lung Adenocarcinoma Detected by BALF Liquid Biopsy (NCT05469022) | Konkuk University Medical Center | 2022-05-19 |
| A Multi-omics Disease Signature Trial in Adult Patients With Moderate to Severe AD (NCT05470114) | LEO Pharma | 2022-05-19 |
| Pembro+Chemo in Brain Mets (NCT04964960) | John L. Villano, MD, PhD | 2022-05-19 |
| A Phase II/III Trial to Evaluate the Efficacy and Safety of QL1706 in Patients With Nasopharyngeal Carcinoma (NCT05576272) | Qilu Pharmaceutical Co., Ltd. | 2022-05-19 |
| Cannabidiol Effects on Craving and Relapse Prevention in Opioid Use Disorder (NCT03787628) | University of California, Los Angeles | 2022-05-19 |
| A Phase Ib Safety lead-in, Followed by Phase II Trial of ADG106 in Combination With Neoadjuvant Chemotherapy in HER2 Negative Breast Cancer (NCT05275777) | National University Hospital, Singapore | 2022-05-19 |
| A Multicenter Study Assessing the Efficacy and Safety of STN1010904 Ophthalmic Suspension 0.03% and 0.1% Compared With Vehicle in Subjects With Fuchs Endothelial Corneal Dystrophy (FECD) (NCT05376176) | Santen Inc. | 2022-05-19 |
| Intensive Therapy Combined With Venetoclax for Adult Acute Myeloid Leukemia (NCT05356169) | Institute of Hematology & Blood Diseases Hospital, China | 2022-05-19 |
| A Phase 2 Study of CDX-0159 in Patients With Chronic Spontaneous Urticaria (NCT05368285) | Celldex Therapeutics | 2022-05-19 |
| A Study to Evaluate the Safety, Tolerability and Efficacy of XEN1101 in Major Depressive Disorder (NCT05376150) | Xenon Pharmaceuticals Inc. | 2022-05-19 |
| A Study of Seltorexant in Participants With Probable Alzheimer's Disease (NCT05307692) | Janssen Research & Development, LLC | 2022-05-19 |
| ECG Validation Study (NCT05445726) | Analog Device, Inc. | 2022-05-19 |
| Study of an Individualized Vaccine Targeting Neoantigens in Combination With Immune Checkpoint Blockade for Patients With Colon Cancer (NCT05456165) | Gritstone bio, Inc. | 2022-05-19 |
| Study to Evaluate the Safety, Tolerability and Efficacy of CT1812 in Subjects With Mild to Moderate Dementia With Lewy Bodies (NCT05225415) | Cognition Therapeutics | 2022-05-19 |
| Mechanistic Study of the Effect of Itepekimab on Airway Inflammation in Patients With COPD (NCT05326412) | Sanofi | 2022-05-19 |
| PD-L1 PET-imaging During CAR T-cell Therapy (NCT05404048) | University Medical Center Groningen | 2022-05-18 |
| Habitat Escalated Adaptive Therapy (HEAT), With Neoadjuvant Radiation for Soft Tissue Sarcoma (NCT05301283) | H. Lee Moffitt Cancer Center and Research Institute | 2022-05-18 |
| Evaluating Safety and Immune Response of Janssen, Moderna, Pfizer/BNT, and Novavax COVID-19 Vaccines for Same and Mixed Boosters in Adolescents and Adults Aged 12-64 With and Without HIV in Kenya, DRC, and Rwanda (NCT07408297) | Victoria Biomedical Research Institute | 2022-05-18 |
| Intraoperative Aromatherapy Versus Placebo for Port-a-Cath Placement Under Monitored Anesthesia Care. A Randomized Controlled Trial (NCT05328973) | M.D. Anderson Cancer Center | 2022-05-18 |
| Simultaneous Hyperpolarized [1-13C]Pyruvate and 18F-FDG PET/MRS in Cancer Patients (NCT05396118) | Rigshospitalet, Denmark | 2022-05-18 |